Background {#Sec1}
==========

Universal childhood vaccination programmes have been described as 'one of the most successful and cost-effective health interventions known' \[[@CR1]\] and form a core component of child health policies in most countries, including the UK \[[@CR2], [@CR3]\]. Achieving high coverage rates of vaccines is critical for establishing 'herd immunity' and preventing disease outbreaks.

Evidence from the UK has identified a number of groups of children who are at risk of not being fully immunised including children: living in more deprived areas; of teenage or lone parents; of unemployed parents; not registered with a GP; with older siblings; from some minority ethnic groups; from non-English speaking families; whose families are travellers, asylum seekers or are homeless \[[@CR4]--[@CR10]\]. Identifying and tailoring interventions to the needs of such 'at risk' groups will be critical to achieving high coverage rates.

A present it is not known whether, in the UK, children with intellectual disabilities constitute one such group. Only two small scale studies have addressed this issue in the UK \[[@CR11], [@CR12]\], although some evidence of lower coverage among children with intellectual disability from population based studies is available from Taiwan \[[@CR13], [@CR14]\] and Australia \[[@CR15]\]. Tuffrey and Finlay \[[@CR12]\] report lower vaccination rates for pertussis, measles and rubella for children with intellectual or physical disabilities attending special schools in one health district in England. More recently, MacLeod and Tuffrey \[[@CR11]\] have reported lower rates of human papillomavirus vaccination among girls attending schools for children with intellectual disability in one health district in England.

Two sources of evidence suggest that it is likely that vaccination coverage among children with intellectual disabilities may be lower than the national average. First, indicators of lower socio-economic position have been associated in the UK with lower childhood vaccination coverage rates (see above) and an increased prevalence of intellectual disability \[[@CR16]\]. Second, there is some limited evidence that historically in the UK paediatricians may have advised parents of children with intellectual and developmental disabilities not to immunise \[[@CR17]\].

The primary aim of our paper is to determine whether, in the UK, children with intellectual disabilities are at risk of non-vaccination. A secondary aim is to determine the extent to which any differences in coverage rates between children with and without intellectual disability may be accounted for by between-group differences in family socio-economic position and/or exposure to other established risk factors for low coverage.

Methods {#Sec2}
=======

We analysed data collected in Waves 1--3 and 6 of the UK's Millennium Cohort Study (MCS). The fourth in the series of British birth cohort studies, MCS is designed to follow a cohort of over 18,000 children born in the UK between 2000 and 2002. MCS data are managed by the Centre for Longitudinal Studies at the University of London ([www.cls.ioe.ac.uk/](http://www.cls.ioe.ac.uk/)) and were downloaded from the UK Data Service (<http://ukdataservice.ac.uk/>). Full details of the design of MCS are available in published reports and technical papers \[[@CR18]--[@CR20]\].

Sampling {#Sec3}
--------

Families were randomly selected from Child Benefit Records, a universal welfare benefit. Sampling was geographically clustered in 398 randomly selected electoral wards in the UK. Sampling was stratified to over-sample children from ethnic minority groups, disadvantaged communities and children born in Wales, Scotland and Northern Ireland \[[@CR21]\]. The first survey (MCS1) took place when children were 9 months old (*n* = 18,552 families). Vaccination information was collected when the children were followed up at ages three (MCS2; 14,898 families interviewed), five (MCS3; 14,678 families interviewed) and 14 (MCS6; 11,173 families interviewed). Information was collected on all children falling within the designated birth date window.

Procedure {#Sec4}
---------

The data used in the present study were collected by either parental report or direct cognitive testing of the child.

Identification of children with intellectual disabilities {#Sec5}
---------------------------------------------------------

Intellectual disability was identified from the results of assessments of child cognitive ability at ages seven, five and 3 years and, for a small number of children for who no test results were available, parental report of receipt of special education services and child attainment. Full details of these procedures have been published in BMC Public Health \[[@CR22]\] and elsewhere \[[@CR23]\]. This procedure led to the identification of 671 of 18,552 (3.6%) children. As expected, boys were significantly more likely than girls to be identified as having intellectual disability (4.3% vs 2.6%; OR = 1.67, 95% CI 1.42--1.96).

Vaccination uptake {#Sec6}
------------------

The UK universal vaccination schedule relevant to the MCS cohort was as follows: (1) due at age 8--16 weeks, primary vaccines (Diphtheria, Tetanus and Pertussis (DTP); *Haemophilus influenzae* type b (Hib); Oral Polio; Meningococcal group C (Men C)); (2) due at age 1, Measles, Mumps and Rubella (MMR); (3) due at age 3 years, 4 months, preschool booster (DTP; Polio - oral or inactivated; MMR); (4) due at age 12--13 human papillomavirus (HPV).

Uptake {#Sec7}
------

Vaccination uptake was based on primary parental informant report. At all Waves informants were requested to consult parent-held child vaccination records to answer questions about vaccinations. At Wave 1 information was only recorded on whether the target child had no, some or all recommended vaccinations. At Waves 2 and 3 information was recorded on the uptake of each recommended vaccination. We used Wave 1 to 3 data to generate three binary summary variables at each Wave (fully or partially vaccinated vs not vaccinated, fully vaccinated vs not vaccinated, partially vaccinated vs not vaccinated). At Wave 6 information was only recorded on whether the target child, if female, had received HPV vaccination. Vaccination coverage data was available for 18,528 children at age 9 months (99.9% of participating children), 14,776 children at age 3 years (99.2% of participating children), 14,650 children at age 5 years (99.8% of participating children) and 5488 girls at age 14 years (98.6% of participating girls).

Reasons given for non-uptake {#Sec8}
----------------------------

At each wave (and at Waves 2 and 3 for each vaccine) parental informants were asked open ended questions about the reason for non-vaccination. Responses were coded by the MCS team into categories that varied across waves both in content and number of categories (up to 44 at Wave 3) Given the small numbers involved we grouped specific reasons into seven categories: parental choice (e.g., concerns about side effects, preference for homeopathic treatments); service/administration errors (e.g., vaccine not available); child unwell at time of vaccination; adverse reactions to previous vaccinations or health-related contra-indication; family disorganisation (e.g., not keeping or making appointment); appointment pending; other (e.g., don't know, vague or irrelevant answer).

Potential confounding variables {#Sec9}
-------------------------------

Given the strong association between immunisation uptake at age 9 months (Wave 1) and subsequent immunisation practices \[[@CR7], [@CR24]\], potential confounding variables were selected from Wave 1 data. Selection was based on availability in MCS data and evidence from previous studies that potential confounders were associated with immunisation uptake and may be more or less common among families of children with intellectual disability when compared to other families. We identified two broad groups of potential confounding variables; indicators of family socio-economic position and other factors associated with family composition and country of residence.

Indicators of family socio-economic position {#Sec10}
--------------------------------------------

Previous research using the MCS has indicated that lower uptake of immunisations was associated with a number of variables indicative of family socio-economic position including residence in a disadvantaged neighbourhood, lone or teenaged parenthood, maternal smoking in pregnancy, maternal educational attainment, maternal employment status and ethnicity \[[@CR6]--[@CR8]\]. Low family socio-economic position is also associated with an increased risk of intellectual disability \[[@CR16]\]. As a result, we included the following indicators of family socio-economic position in our analyses:Income poverty: operationalised as living in a household with equivalised income lower than 60% of the national median \[[@CR25]\].Low household assets: operationalised as lacking two or more household assets from a list of eight common household assets (e.g., fridge, freezer, washing machine, microwave, home computer).Living in workless household: operationalised as no adult in the household being in paid employment.Maternal educational attainment: operationalised on the basis of parental informant report as degree/diploma level, GCSE grade C or above, lower than GCSE grade C or above.Residence in a disadvantaged neighbourhood: operationalised as living in an area in the lowest national quintile on a measure of multiple deprivation (e.g., \[[@CR26]\]).Lone parenthood: operationalised as not cohabiting with another parent figure.

Other potential confounders {#Sec11}
---------------------------

Previous research using the MCS has indicated that lower uptake of immunisations was associated with a number of other variables not necessarily associated with family socio-economic position including living with siblings, younger and older mothers, minority ethnicity, child born in England (as opposed to other home countries), maternal smoking in pregnancy and child hospital admission in first 9 months of life \[[@CR6]--[@CR8]\]. While the association between most of these variables and risk of intellectual disability is unknown, we included them in our analyses (primarily as binary variables) based on parental informant report at Wave 1. The one exception to their inclusion as binary variables was maternal age which was included as a four-level ordinal variable based on population quartiles (14--23, 24--28, 29--32, 33+).

Approach to analysis {#Sec12}
--------------------

All analyses were undertaken in Stata 10 SE using svy command to take account of the initial sampling design and biases in recruitment and retention at each Wave \[[@CR27]\]. To avoid the statistical problems associated with the clustering of multiple births within households, the present analyses are restricted to the first named target child in multiple birth households.

First, bivariate descriptive analyses were undertaken to estimate vaccination coverage rates (with 95% confidence intervals) for children with and without intellectual disabilities. Chi Square was used to test the statistical significance of between group differences in coverage rates.

In the second stage of analysis we used Poisson regression to calculate prevalence rate ratios (PRRs) to estimate the strength and statistical significance of differences in vaccination coverage rates between children with and without intellectual disabilities \[[@CR28], [@CR29]\]. The base for these analyses was children without intellectual disability. The dependent variable was the probability of not being vaccinated. PRRs were estimated under three conditions: (1) simple unadjusted; (2) adjusted for potential confounding variables associated with family socio-economic position; (3) adjusted for all potential confounding variables.

All analyses used the Stata 'syv' commands to address the complex clustered sample design and utilised supplied sampling weights to take account of biases in initial recruitment and retention.

Results {#Sec13}
=======

Vaccination coverage rates and prevalence rate ratios for non-uptake of vaccinations are presented in Table [1](#Tab1){ref-type="table"}. For all ages and for both groups of children complete coverage rates are high (range 84.9--95.2%). However, with one exception (MMR coverage at age 5) coverage rates were lower for children with intellectual disabilities. Complete coverage rates were significantly lower for children with intellectual disabilities at ages 9 months (unadjusted PRR = 2.03 (1.14--3.60), *p* \< 0.05) and 3 years (unadjusted PRR = 2.16 (1.06--4.43), *p* \< 0.05), but not at age 5 years (unadjusted PRR = 1.91 (0.67--5.49)). Adjusting PRRs for between group differences in family socio-economic position and other factors associated with coverage significantly reduced the strength of association between intellectual disability and coverage at age 9 months and non-significantly reduced the strength of association between intellectual disability and coverage at ages three and 5 years.Table 1Vaccination coverage among children with and without intellectual disabilities in the UK% Vaccination coverage (with 95% CI)Rate ratios for *non-uptake* among children with intellectual disability (reference group = other children)Children with intellectual disabilitiesOther childrenUnadjustedModel 1 (SEP)Model 2 (SEP + other factors)Age 9 months(*n* = 551)(*n* = 17,986) Fully or partially vaccinated97.6% (95.7--98.6)98.7% (98.5--99.0)1.93 (1.09--3.43)\*1.33 (0.69--2.57)1.33 (0.71--2.53) Fully vaccinated89.5% (86.2--92.1)95.2% (94.8--95.7)2.03 (1.14--3.60)\*1.38 (0.71--2.637)1.38 (0.73--2.63) Partially vaccinated8.0% (5.8--11.0)3.5% (3.2--3.9)0.88 (0.53--1.47)0.90 (0.50--1.63)0.96 (0.54--1.70) No vaccinations2.4% (1.4--4.3)1.3% (1.1--1.6)Age 3 years(*n* = 521)(*n* = 14,261) Polio complete97.3% (95.1--98.6)98.8% (98.6--99.0)2.27 (1.20--4.29)\*2.22 (1.16--4.23)\*2.18 (1.13--4.19)\* Diptheria complete98.2% (96.3--99.1)98.8% (98.6--99.1)1.59 (0.78--3.23)1.48 (0.70--3.13)1.47 (0.70--3.15) Tetanus complete97.7% (95.8--98.8)98.9% (98.6--99.1)2.02 (1.07--3.82)\*1.89 (0.97--3.66)1.90 (0.97--3.71) Pertussis complete96.4% (93.8--98.0)98.4% (98.1--98.7)2.23 (1.27--3.92)\*\*2.07 (1.16--3.70)\*2.12 (1.19--3.79)\* Hib complete96.5% (93.9--98.0)98.2% (97.8--98.5)1.95 (1.10--3.45)\*1.78 (0.98--3.23)1.78 (0.98--3.23) Meningitis complete96.7% (94.2--98.1)98.1% (97.7--98.4)1.73 (0.98--3.07)1.59 (0.87--2.92)1.62 (0.87--3.01) MMR91.6% (88.1--94.2)93.9% (93.2--94.6)1.38 (0.96--1.09)1.24 (0.85--1.80)1.18 (0.81--1.72) Fully or partially vaccinated98.1% (96.2--99.0)99.1% (98.8--99.3)2.06 (1.01--4.22)\*1.77 (0.82--3.79)1.78 (0.83--3.81) Fully vaccinated84.9% (80.8--88.3)90.1% (89.2--90.9)2.16 (1.06--4.43)\*1.82 (0.85--3.92)1.83 (0.86--3.91) Partially vaccinated13.2% (10.1--17.1)9.0% (8.2--9.7)1.35 (0.70--2.63)1.35 (0.66--2.77)1.35 (0.66--2.75) No vaccinations1.9% (1.0--3.8)0.9% (0.7--1.2)Age 5 years(*n* = 524)(n = 14,365) Booster DTP94.5% (91.9--96.3)96.0% (95.5--96.4)1.38 (0.92--2.06)1.19 (0.79--1.79)1.17 (0.77--1.77) All 3 doses combined DTP98.7% (97.0--99.5)99.2% (98.9--99.4)1.56 (0.64--3.81)1.43 (0.54--3.77)1.36 (0.51--3.63) Booster polio94.9% (92.4--96.7)95.2% (94.6--95.7)1.06 (0.69--1.61)0.99 (0.64--1.94)0.98 (0.63--1.54) All three doses Polio98.7% (97.1--99.5)99.2% (99.0--99.4)1.61 (0.68--3.79)1.57 (0.62--4.01)1.51 (0.60--3.84) All 3 doses Meningitis C97.8% (95.5--98.9)98.4% (98.1--98.7)1.40 (0.70--2.82)1.33 (0.63--2.79)1.32 (0.63--2.74) MMR96.9% (95.0--98.1)96.8% (96.2--97.2)0.96 (0.58--1.58)1.07 (0.64--1.79)1.01 (0.60--1.70) Fully or partially vaccinated99.1% (97.4--99.7)99.5% (99.3--99.6)1.88 (0.66--5.39)2.01 (0.61--6.59)1.93 (0.59--6.35) Fully vaccinated87.4% (83.9--90.2)89.3% (88.4--90.1)1.91 (0.67--5.49)1.97 (0.60--6.44)1.88 (0.58--6.13) Partially vaccinated11.7% (9.1--14.9)10.2% (9.5--11.1)1.60 (0.59--4.36)2.18 (0.69--6.88)2.20 (0.72--6.77) No vaccinations1.0% (0.3--2.7)0.5% (0.4--0.7)Age 14 years(*n* = 149)(*n* = 4938) HPV (girls only)87.4% (77.9--93.2)93.1% (92.1--94.0)1.83 (0.99--3.37)1.59 (0.83--3.03)1.52 (0.78--2.98)Note: \* *p* \< 0.05, \*\* *p* \< 0.01, \*\*\* *p* \< 0.001*N* = weighted sample size

Reasons given by informants for non-vaccination are presented in Table [2](#Tab2){ref-type="table"}. There were few statistically significant between group differences in the probability of citing specific reasons for non-vaccination. The only consistent differences were that at age 9 months and 3 years reasons for non-vaccination based on parental choice were significantly more frequently cited by parents of children without intellectual disability. The high rates of parental choice reasons given at age 3 were primarily driven by low uptake of, and concerns about the safety of, MMR vaccination.Table 2Parental reasons given for non-vaccinationReasonChild ageChildren with intellectual disabilities (% with 95% CI)Other children (% with 95% CI)Adjusted FParental choice9 months1.3% (0.3--4.5)10.2% (7.3--14.0)14.85\*\*\*3 years62.5% (47.3--75.5)76.8% (73.9--79.5)4.40\*5 years16.0% (7.2--31.9)14.8% (12.4--17.5)0.0414 years46.7% (20.1--75.4)42.0% (35.7--48.6)0.09Service/administration errors9 months8.0% (1.9--27.7)9.1% (6.5--12.5)0.033 years5.1% (1.3--17.5)3.6% (2.7--4.7)0.275 years30.9% (18.3--47.2)26.1% (23.1--29.3)0.4214 years14.7% (3.5--45.4)12.8% (9.2--17.6)0.04Child unwell at time of planned vaccination9 months8.6% (3.1--21.4)39.9% (35.1--44.8)0.533 years8.6% (3.1--21.4)6.3% (5.1--7.9)0.365 years3.3% (1.1--9.4)5.6% (4.1--7.7)0.9314 years13.5% (2.0--54.7)9.3% (5.8--14.5)0.15Adverse reactions or health-related contra-indication9 months5.9% (1.5--20.6)9.1% (6.6--12.4)0.393 years8.7% (3.3--21.2)9.3% (7.8--11.0)0.025 years20.1% (9.9--36.5)5.7 (4.4--7.5)12.97\*\*\*14 years0.0% (0.0--16.8)1.6% (0.6--4.3)0.21Family disorganisation9 months8.9% (2.7--26.0)14.5% (11.3--18.4)0.703 years3.6% (0.5--21.0)2.9% (2.1--4.1)0.045 years0.0% (0.0--8.0)5.7% (4.4--7.3)1.9714 years0.0% (0.0--16.8)11.0% (7.5--15.8)1.42Appointment pending9 months25.8% (13.2--44.4)20.8% (17.0--25.2)0.393 years1.8% (0.5--6.4)3.1% (2.2--4.3)0.655 years21.8% (10.6--39.7)30.0% (26.8--37.5)0.9514 yearsInformation not collectedOther9 months15.4% (6.5--32.5)12.0% (9.1--15.7)0.323 years20.8% (11.6--34.6)12.0% (10.1--14.2)3.525 years14.9% (6.6--30.2)24.4% (21.3--27.9)1.8314 years25.1% (7.8--56.9)26.4% (20.7--32.9)0.01Note: Base for % is the number of parents giving one or more reason at each wave\* *p* \< 0.05, \*\*\*\* *p* \< 0.001

Discussion {#Sec14}
==========

This is the first study to report on early childhood vaccination coverage among a nationally representative sample of UK children with and without intellectual disability. The main findings are: (1) at ages 9 months, three and 5 years complete coverage rates are reasonably high for both groups of children; (2) with one exception (MMR coverage at age 5) coverage rates were lower for children with intellectual disabilities for all vaccinations (when compared to children without intellectual disability); (3) complete coverage rates were significantly lower for children with intellectual disabilities at ages 9 months and 3 years, and lower (but not significantly so) at age 5 years; (4) while adjusting PRRs for between group differences in family socio-economic position and other factors associated with coverage reduced the strength of association between intellectual disability and coverage at all ages, incomplete vaccination remained significantly elevated for children with intellectual disabilities at ages 9 months and 3 years; (5) there were no statistically significant differences between parents of children with/without intellectual disability regarding the broad classes of reasons given for non-vaccination. These results are broadly consistent with evidence of lower coverage among children with intellectual disability from population based studies undertaken in Taiwan \[[@CR13], [@CR14]\] and Australia \[[@CR15]\].

The results suggest that a significant proportion of the risk of non-uptake among children with intellectual disability is plausibly related to the association between intellectual disability and lower family socio-economic position. However, risk of non-vaccination among children with intellectual disability remained elevated when controlling for these between-group, differences. Further research including mixed methods and qualitative studies is needed to identify the reasons for non-vaccination among children with intellectual disabilities, especially in early childhood prior to school entry. At 9 months of age, less than 5% of parents of children with intellectual disability reported that non-vaccination was a matter of parental choice, while 65% reported other reasons including apparent service failures (e.g., cancelled appointment), child illness at the time of appointment, missed appointments and parents being unaware that vaccination was recommended. While dominance of other reasons was reversed at age three (with just under 50% of parents of children with intellectual disability reported that non-vaccination was a matter of parental choice), it needs to be kept in mind that these data were primarily collected in 2003 at the peak of the controversy of the association between the combined MMR vaccine and autism \[[@CR6]\].

The results also suggested that differences in primary vaccination coverage are minimal at age 5 (an age at which all children will have entered school). While children with intellectual disabilities do appear to catch up with their peers with regards to vaccination coverage, it should be noted that children receiving vaccinations late remain susceptible to vaccine preventable diseases which may jeopardise their own health, the health of younger siblings and may also compromise herd immunity increasing the risk of disease outbreaks \[[@CR30]\].

The primary strength of the present study lies in its use of a sizable cohort of children representative of the population of children growing up in the UK at the beginning of the new millennium. However, as in all studies, there were limitations that impact the interpretation of these findings. First, the MCS utilised abbreviated scales of cognitive functioning (rather than complete IQ tests). While it is common practice in such instances to derive a proxy measure of IQ (cf., \[[@CR22], [@CR31], [@CR32], [@CR33]\]), the association between the proxy and full measure is unknown. As a result, it is possible that there was some misclassification of intellectual disability status. Second, while the overall sample was relatively large, it was of insufficient size to disaggregate results for the intellectual disability group by such potentially important factors as gender, ethnicity and severity of intellectual disability. Finally, while evidence in general suggests that parental report may be an unreliable measure of vaccination \[[@CR34]\], recent research using the MCS and linked data in Wales has reported high concordance between parental reported and child health recorded MMR status \[[@CR30]\].

Conclusions {#Sec15}
===========

Children with intellectual disabilities in the UK are at increased risk of vaccine preventable diseases. This may jeopardise their own health, the health of younger siblings and may also compromise herd immunity.
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